key: cord-0996980-i4nus208 authors: Espirito Santo, D. A.; Lemos, A. C. B.; Miranda, C. H. title: In vivo demonstration of microvascular thrombosis in severe Covid-19 date: 2020-07-11 journal: nan DOI: 10.1101/2020.07.09.20149971 sha: 16514594d0780df438173d88932ec1fe5f657e92 doc_id: 996980 cord_uid: i4nus208 Several autopsies studies showed the presence of microthrombi in the pulmonary circulation of the severe COVID-19. The major limitation of these investigations is that the autopsy provided static information. Some of these alterations could be secondary to the disseminated intravascular coagulation (DIC) observed as the final common pathway of the multisystem organ failure exhibited in the critical patient. We report the preliminary results of an in vivo evaluation of the sublingual microcirculation in thirteen patients with severe COVID-19 requiring mechanical ventilation at the beginning of the hospitalization. They did not have any laboratorial DIC evidence. We observed multiple filling defects moving within the sublingual microvessels indicative of microthrombi in 11 (85%) patients. This is the first imaging documentation of microvascular thrombosis in living patients with severe COVID-19. The clinical relevance of microvascular thrombosis in this disease requires further research. Several autopsies studies showed the presence of microthrombi in the pulmonary circulation of the severe COVID-19. The major limitation of these investigations is that the autopsy provided static information. Some of these alterations could be secondary to the disseminated intravascular coagulation (DIC) observed as the final common pathway of the multisystem organ failure exhibited in the critical patient. We report the preliminary results of an in vivo evaluation of the sublingual microcirculation in thirteen patients with severe COVID-19 requiring mechanical ventilation at the beginning of the hospitalization. They did not have any laboratorial DIC evidence. We observed multiple filling defects moving within the sublingual microvessels indicative of microthrombi in 11 (85%) patients. This is the first imaging documentation of microvascular thrombosis in living patients with severe COVID-19. The clinical relevance of microvascular thrombosis in this disease requires further research. Keywords: COVID-19; microvascular thrombosis; sublingual microcirculation; coagulopathy . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 11, 2020. . https://doi.org/10.1101/2020.07.09.20149971 doi: medRxiv preprint The main clinical presentation of patients with severe coronavirus disease 2019 is an acute respiratory failure with significant hypoxemia, which requires mechanical ventilation [1] . In addition to the gas exchange involved, recently published investigations described a high incidence of thrombotic events in these patients [2] . Several autopsies studies demonstrated the presence of microthrombi in the pulmonary circulation [3] [4] [5] [6] . The major limitation of these investigations is that the autopsy provided static information. Some of these alterations could be secondary to the disseminated intravascular coagulation (DIC) observed as the final common pathway of the multisystem organ failure exhibited in the critical patient. To support the microvascular thrombosis occurrence in severe COVID-19 pathophysiology, we report the preliminary results of an in vivo evaluation of the sublingual microcirculation allowing the dynamic visualization of these microvessels. We included adult patients with SARS-Cov-19 virus infection confirmed through reverse transcriptase-polymerase chain reaction (RT-PCR) of nasopharyngeal swabs and severe clinical presentation with respiratory failure requiring mechanical ventilation. The sublingual microcirculation visualization was performed with the patient in dorsal decubitus with the headboard raised to 45 degrees. We used the Capiscope HVCS handheld video capillaroscopy system (KK Technology, Honiton, England, UK), and imaging was analyzed using the Glycocheck system (Microvascular health solution, American Fork, UT, USA). The camera, protected with disposable tips, was placed under the tongue without pressing this instrument in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 11, 2020. . https://doi.org/10.1101/2020.07.09.20149971 doi: medRxiv preprint at least five different regions inside the mouth after the patient's admission into the intensive care unit. The ethical board of our institution approved this investigation. The relatives of the patients gave their written informed consent to participate in this research. We analyzed the imaging of the sublingual microcirculation of thirteen patients on the first day after hospital admission. The demographics, clinical, and laboratory characteristics of these patients are presented in Table 1 . All the patients were on mechanical ventilation, and they did not have any evidence of circulatory shock. Six patients (46%) were receiving a low norepinephrine dose to support sedation and neuromuscular blocking agents, both of them with normal lactate. None of these patients met the criteria for DIC. Despite elevated D-dimer levels, prothrombin time, and activated partial thromboplastin time (aPTT) were normal, fibrinogen levels were increased in all patients, and mild thrombocytopenia was observed in only two patients. We observed some evidence of microvascular thrombosis in 11 (85%) patients. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 11, 2020. . https://doi.org/10.1101/2020.07.09.20149971 doi: medRxiv preprint Thrombus in small vessels of the pulmonary circulation is a common finding in the autopsies of COVID-19 patients. Dolhnikoff et al. [3] observed a variable number of small fibrinous thrombi in small pulmonary arterioles in areas of both damaged and more preserved lung parenchyma in 8 out of 10 cases in the minimally invasive autopsy. Small fibrinous thrombi were rarely found in the glomeruli and superficial dermal vessels. Ackermann et al. [4] examined seven lungs obtained during the autopsy and found widespread pulmonary vessels' thrombosis. Fox et al. [5] observed the presence of thrombosis and microangiopathy in the lungs' small vessels in autopsies of ten African American decedents. Carsana et al. [6] analyzed lung tissue samples of 38 patients, besides the diffuse alveolar damage, they observed fibrin thrombi in the small arterial vessels in 87% of cases, around half of which had more involvement than 25% of the lung tissue. Our investigation demonstrated thrombi in microcirculation since the beginning of the hospitalization, and none of these patients had criteria for DIC. This finding reinforces that microvascular thrombosis is a hallmark of the COVID-19. Another conclusion emphasized by our investigation is that microvascular thrombosis occurs systemically, and it could affect different organs. Probably those organs with a high capillary density, such as the lungs, are the most compromised. In the lung, pulmonary microvascular thrombosis could lead to a dead space effect (ventilated areas, but not perfused), contributing to the critical hypoxemia observed in these cases. However, microvascular thrombosis could compromise other areas such as the kidney, liver, and brain, contributing to multiple organ dysfunction, such as recent descriptions [7] . This mechanism could explain the findings of Tang et al. [8] , who in a retrospective study achieved a low 28-day mortality in severe Covid-19 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 11, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 11, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 11, 2020. . https://doi.org/10.1101/2020.07.09.20149971 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 11, 2020. . https://doi.org/10.1101/2020.07.09.20149971 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 11, 2020. . https://doi.org/10.1101/2020.07.09.20149971 doi: medRxiv preprint Severe Covid-19 Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Marcia Negri E (2020) Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted July 11, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 11, 2020. . https://doi.org/10.1101/2020.07.09.20149971 doi: medRxiv preprint